Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Osamu Fujii, Yusuke Demizu, Naoki Hashimoto, Masaru Takagi, Kazuki Terashima, Masayuki Mima, Dongcun Jin, Fumiko Nagano, Kuniaki Katsui, Tomoaki Okimoto, Hiromitsu Iwata, Yasue Niwa, Tomohiro Yamashita, Takashi Akagi, Takashi Daimon, Ryohei Sasaki, Yoshio Hishikawa, Mitsuyuki Abe, Masao Murakami & Nobukazu Fuwa. (2015) Particle therapy for clinically diagnosed stage I lung cancer: Comparison with pathologically proven non-small cell lung cancer. Acta Oncologica 54:3, pages 315-321.
Read now
Read now
Oscar Casares-Magaz, Jakob Toftegaard, Ludvig P. Muren, Jesper F. Kallehauge, Niels Bassler, Per R. Poulsen & Jørgen B. B. Petersen. (2014) A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer. Acta Oncologica 53:8, pages 1058-1063.
Read now
Read now
Eirik Malinen & Ludvig Paul Muren. (2014) Image guided therapy – Do we get the picture?. Acta Oncologica 53:1, pages 3-5.
Read now
Read now
Cai Grau, Morten Høyer, Markus Alber, Jens Overgaard, Jacob Christian Lindegaard & Ludvig Paul Muren. (2013) Biology-guided adaptive radiotherapy (BiGART) – more than a vision?. Acta Oncologica 52:7, pages 1243-1247.
Read now
Read now
Ludvig P. Muren, Carl Rossi, Eugen Hug, Andrew Lee & Bengt Glimelius. (2013) Establishing and expanding the indications for proton and particle therapy. Acta Oncologica 52:3, pages 459-462.
Read now
Read now
Rovel J. Colaco, Soon Huh, Romaine C. Nichols, Christopher G. Morris, Harry D’Agostino, Stella Flampouri, Zuofeng Li, Dat C. Pham, Abubakr A. Bajwa & Bradford S. Hoppe. (2013) Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncologica 52:3, pages 506-513.
Read now
Read now
Morten Høyer & Ludvig P. Muren. (2012) Stereotactic body radiation therapy – A discipline with Nordic origin and profile. Acta Oncologica 51:5, pages 564-567.
Read now
Read now
Håkan Nyström, Erik Blomqvist, Morten Høyer, Anders Montelius, Ludvig Paul Muren, Per Nilsson, Zahra Taheri-Kadkhoda & Bengt Glimelius. (2011) Particle Therapy – A next logical step in the improvement of radiotherapy. Acta Oncologica 50:6, pages 741-744.
Read now
Read now
Articles from other publishers (21)
Şule Terzioğlu-Uşak, Cem Horozoğlu, Şeyda Demirkol, Akif Turna & İlhan Yaylım. (2021) The role of galectin-3 and its genetic variants in tumor risk and survival of patients with surgically resected early-stage non-small cell lung cancer. Turkish Journal of Thoracic and Cardiovascular Surgery 29:2, pages 212-222.
Crossref
Crossref
Junjun Mou, Tao Hu, Zhiwu Wang, Wei Chen, Yang Wang & Wei Zhang. (2020) ATM gene polymorphisms are associated with poor prognosis of non-small cell lung cancer receiving radiation therapy. Aging 12:8, pages 7465-7479.
Crossref
Crossref
Jia-Chun Liu, Suresh Narva, Kang Zhou & Wen Zhang. (2019) A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors. Mini-Reviews in Medicinal Chemistry 19:18, pages 1517-1530.
Crossref
Crossref
Wei Wang, Xia-Bo Shen, Wei Jia, Da-Bing Huang, Yong Wang & Yue-Yin Pan. (2019) The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis. Therapeutic Advances in Medical Oncology 11, pages 175883591985066.
Crossref
Crossref
Alexander Chi, Lien-Chun Lin, Sijin Wen, Haijuan Yan & Wen-Chien Hsi. (2017) Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy. Radiation Oncology 12:1.
Crossref
Crossref
Daniela Bettega, Paola Calzolari, Mario Ciocca, Angelica Facoetti, Miriam Lafiandra, Renato Marchesini, Silvia Molinelli, Emanuele Pignoli & Barbara Vischioni. (2017)
Combining proton or photon irradiation with epothilone B. An
in vitro
study of cytotoxicity in human cancer cells
. Biomedical Physics & Engineering Express 3:5, pages 055009.
Crossref
Crossref
Marina Cardó-Vila, Serena Marchiò, Masanori Sato, Fernanda I. Staquicini, Tracey L. Smith, Julianna K. Bronk, Guosheng Yin, Amado J. Zurita, Menghong Sun, Carmen Behrens, Richard L. Sidman, J. Jack Lee, Waun K. Hong, Ignacio I. Wistuba, Wadih Arap & Renata Pasqualini. (2016) Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer. The American Journal of Pathology 186:8, pages 2162-2170.
Crossref
Crossref
Judit Boda-Heggemann, Anian Frauenfeld, Christel Weiss, Anna Simeonova, Christian Neumaier, Kerstin Siebenlist, Ulrike Attenberger, Claus Peter Heußel, Frank Schneider, Frederik Wenz & Frank Lohr. (2014) Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases. Radiation Oncology 9:1.
Crossref
Crossref
Fenglei Wu, Jian Zhang, Nan Hu, Huiyu Wang, Tongpeng Xu, Yi Liu & Yitong Zheng. (2014) Effect of hENT1 polymorphism G-706C on clinical outcomes of gemcitabine-containing chemotherapy for Chinese non-small-cell lung cancer patients. Cancer Epidemiology 38:6, pages 728-732.
Crossref
Crossref
Saet-Byul Oh, Chul Ju Hwang, Suk-Young Song, Yu Yeon Jung, Hyung-Mun Yun, Chang Hyun Sok, Ha Chang Sung, Jin-Mu Yi, Dong Hyun Park, Young Wan Ham, Sang Bae Han, Bang Yeon Hwang & Jin Tae Hong. (2014) Anti-cancer effect of tectochrysin in NSCLC cells through overexpression of death receptor and inactivation of STAT3. Cancer Letters 353:1, pages 95-103.
Crossref
Crossref
Timur MitinAnthony L. Zietman. (2014) Promise and Pitfalls of Heavy-Particle Therapy. Journal of Clinical Oncology 32:26, pages 2855-2863.
Crossref
Crossref
Barbara Vanderstraeten, Wilfried De Neve, Yolande Lievens, Jan Verstraete & Roger De Croock. (2014) In Reply to de Ruysscher et al. International Journal of Radiation Oncology*Biology*Physics 90:1, pages 239.
Crossref
Crossref
C. Faivre-Finn. (2014) Cancers bronchiques non à petites cellules localement avancés : quelle radiothérapie en 2014 ?. Revue des Maladies Respiratoires Actualités 6:4, pages 421-430.
Crossref
Crossref
Alexander Chi, Nam Phong Nguyen & Ritsuko Komaki. (2014) The Potential Role of Respiratory Motion Management and Image Guidance in the Reduction of Severe Toxicities Following Stereotactic Ablative Radiation Therapy for Patients with Centrally Located Early Stage Non-Small Cell Lung Cancer or Lung Metastases. Frontiers in Oncology 4.
Crossref
Crossref
Michael Orth, Kirsten Lauber, Maximilian Niyazi, Anna A. Friedl, Minglun Li, Cornelius Maihöfer, Lars Schüttrumpf, Anne Ernst, Olivier M. Niemöller & Claus Belka. (2013) Current concepts in clinical radiation oncology. Radiation and Environmental Biophysics 53:1, pages 1-29.
Crossref
Crossref
Marianna Christodoulou, Neil Bayman, Paula McCloskey, Carl Rowbottom & Corinne Faivre-Finn. (2014) New radiotherapy approaches in locally advanced non-small cell lung cancer. European Journal of Cancer 50:3, pages 525-534.
Crossref
Crossref
Ludvig P. Muren & David I. Thwaites. (2013) The on-going quest for treatment precision and conformality in radiotherapy. Radiotherapy and Oncology 109:3, pages 337-341.
Crossref
Crossref
Elisabeth Steiner, Markus Stock, Boris Kostresevic, Alexander Ableitinger, Urszula Jelen, Hannah Prokesch, Alina Santiago, Petra Trnková, Adam Wolf, Andrea Wittig, Antony Lomax, Oliver Jäkel, Guido Baroni & Dietmar Georg. (2013) Imaging dose assessment for IGRT in particle beam therapy. Radiotherapy and Oncology 109:3, pages 409-413.
Crossref
Crossref
S.E. Combs & J. Debus. 2013. Strahlentherapie. Strahlentherapie
557
591
.
Fenglei Wu, Nan Hu, Yu Li, Baoxiang Bian, Guanghui Xu & Yitong Zheng. (2012) Galectin-3 genetic variants are associated with platinum-based chemotherapy response and prognosis in patients with NSCLC. Cellular Oncology 35:3, pages 175-180.
Crossref
Crossref
Christoph Bert, Rita Engenhart-Cabillic & Marco Durante. (2012) Particle therapy for noncancer diseases. Medical Physics 39:4, pages 1716-1727.
Crossref
Crossref